Skip to main content

Table 4 VFQ-39 total scores stratified by visits, treatment type, and disease activity

From: Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study

 

Baseline

Month 6

Difference

P value

Treatment type

    

 Group 1

73.59

78.08

4.49

0.090

 Group 2

71.16

80.71

9.54

0.005

Disease activity

    

 Category 1

57.95

69.24

11.28

0.057

 Category 2

77.09

83.78

6.69

0.027

 Category 3

77.77

81.87

4.09

0.2209

  1. P values were calculated using paired t test.